Abstract
Purpose
Genetic variants determine the predisposition of an individual to obesity in a given environment. The present study was conducted to seek an association of the FTO variant rs1421085 with overweight/obesity and related traits in 612 Pakistani subjects in a case–control manner (overweight/obese = 306 and non-obese = 306). Moreover, interaction effects of the rs1421085 and overweight/obesity on multiple metabolic traits were also investigated, which were never explored before in Pakistani as well as in any other population.
Materials and methods
Anthropometric traits were measured by standard procedures, while metabolic parameters were determined by biochemical assays. Genotyping of the rs1421085 was carried out by TaqMan allelic discrimination assay. The data were analysed using SPSS software version 19.
Results
The study revealed a significant association of the rs1421085 with overweight/obese phenotype with respect to over-dominant model indicated by h-index. The CT genotype of the rs1421085 was observed to increase the risk of being overweight/obese by 1.583 times (95% CI 1.147–2.185, p = 0.005). The CT genotype was also found to be associated with higher values of all anthropometric variables (except height and waist-to-hip ratio). Moreover, the interaction between the CT genotype of the rs1421085 and overweight/obesity was found to influence several metabolic parameters (raised blood pressure, product of triglyceride and glucose index, triglyceride levels, LDL-C, VLDL-C, coronary risk index, atherogenic index, and triglyceride-to-HDL-C ratio).
Conclusion
In conclusion, the rs1421085 was found to be associated with overweight/obesity and related anthropometric traits independent of age and gender in Pakistani population. Moreover, this variant was found to influence various metabolic traits in the presence of overweight/obesity.
Level of evidence
Level III, case–control analytic study.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Obesity is a complex disorder that is caused by multiple factors [1]. Importantly, obesity is an outcome of interplay between environment and genetic makeup of an individual or a population. The risk genotypes of genetic variants may have more pronounced expression in the presence of obesogenic factors such as energy-dense foods and physical inactivity [2]. Nonetheless, obesity is primarily genetically determined; therefore, contribution of genetic factors cannot be overlooked. Genetic makeup of an individual greatly influences body mass index via affecting metabolism, appetite, and tendency for physical activity [3]. Twin and adoption studies provided significant evidence for a genetic component of obesity [4]. Several genes are involved in the process of energy regulation as well as in adipogenesis. Thus, variations in these genes may predispose an individual to obesity [5,6,7]. Genetic heterogeneity and allelic diversity exist throughout different populations of the world even in the populations living exclusively at a very restricted geographical area [8,9,10]. A study has confirmed an indisputable impact of common genetic variants on obesity predisposition in a population-specific manner [11]. Therefore, the association of the genetic variants with respective phenotypes must be studied at population level. Pakistani population provides an opportunity for the research community to explicate the interaction between obesogenic environmental modifications and obesity-predisposing genes due to its unique characteristics such as complex demographic history, ethnic diversity, consanguinity, large pedigrees, and current nutritional shift [12].
In genome-wide association studies (GWAS), among numerous obesity-linked genes, the strongest signal has been detected with the fat mass and obesity-associated (FTO) gene [13, 14]. The FTO was found to be expressed in many tissues in humans and animals. However, FTO mRNA is abundantly found in the hypothalamus of brain that controls energy balance [15, 16]. Thus, any functional variation in the FTO gene may affect energy balance and may lead to manifestation of overweight/obese phenotype. The rs1421085 of the FTO gene (involving T → C transition) has recently been predicted as the causal variant for obese phenotype [17]. However, the association of the FTO rs1421085 variant with obesity and obesity-related parameters has never been studied in Pakistani population. Moreover, the interactive effects of the FTO rs1421085 and overweight/obesity (FTO rs1421085 × overweight/obesity) on metabolic parameters were never explored before in Pakistani as well as in any other population. Therefore, the current study was carried out to find the association of the FTO rs1421085 with overweight/obese phenotype and anthropometric and metabolic parameters in a sample of Pakistani individuals. In addition, aforementioned effects of interaction have also been sought in this study.
Materials and methods
Study population
It was a case–control study, which was performed at Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), University of Karachi, Pakistan, after approval from Advanced Studies and Research Board and ethical committee of the institute. The study encompassed a total of 612 Pakistani subjects including 306 overweight/obese cases and equal number of their age- (± 5 years) and gender-matched non-obese subjects (n = 306). Simple random sampling technique (without replacement) was employed for the recruitment of subjects. The study subjects were between the ages of 12–63 years. Reference ranges for BMI (≥ 25 kg/m2 for overweight and ≥ 30 kg/m2 for obesity) in adult subjects (≥ 20 years) were followed as recommended by World Health Organization (WHO), whereas for children and adolescents (< 20 years), BMI reference ranges (85th–94th percentile for overweight and ≥ 95th percentile for obesity) were followed according to the growth charts given by Center for Disease Control and Prevention (CDC). Subjects with any type of endocrinopathy and medication history of drugs that may increase body weight were not included in the study. Moreover, the study involved those overweight/obese cases, whose diabetic status was not known, so that we can also find the association of the variant with the obesity-mediated impaired metabolic parameters that may eventually lead to diabetes. Informed consents were obtained from all study subjects before participation in the study.
Blood sample collection
Blood sample (5 mL) was collected following an overnight fasting of 8–12 h. The isolated blood was utilized for subsequent serum and DNA isolation.
Anthropometric parameters
Anthropometric measurements including body height, weight, body mass index (BMI), waist circumference (WC), hip circumference (HC), and skinfold thicknesses from various sites (biceps, triceps, abdomen, suprailliac, sub-scapular, and thighs) were taken from each subject by following standard procedures. The waist-to-stature ratio (WSR) was calculated via dividing the values of WC by the values of height. The measurements of waist and hip circumference were used to determine waist-to-hip ratio (WHR = WC ÷ HC). Sum of skinfold thicknesses (SFTs) was used to compute body fat percentage (% BF) via gender-specific formulae [18]. For males: % BF = [(0.29288 × sum of skin folds) − {0.0005 × (sum of skin folds)2} + {(0.15845 × age) − 5.76377.2}], for females: % BF = [(0.29669 × sum of skinfolds) − {0.00043 × (sum of skinfolds)2} + {(0.02963 × age) + 1.4072}].
Metabolic estimations
Systolic and diastolic blood pressure was measured from right arm of the subject using mercury sphygmomanometer (CR-2001, Certeza medical, Germany) with 1 mm Hg accuracy. Concentration of fasting blood glucose was evaluated using blood glucose monitoring system (Abbott, UK). Serum insulin levels were determined by enzyme-linked immunosorbent assay (ELISA) using commercial kit (DIA source, Belgium) as per instructions of manufacturer’s protocol. Homeostatic model assessment–insulin resistance (HOMA–IR) was calculated by computing values of fasting glucose and insulin in the corresponding formula [19]. All lipid parameters including serum triglycerides (TG), total cholesterol (TC), high-density-lipoprotein cholesterol (HDL-C), and low-density-lipoprotein cholesterol (LDL-C) were measured using parameter-specific assay kits (Merck, Darmstadt, Germany) involving enzymatic colorimetric assay on an automatic chemistry analyzer (Roche Hitachi 902, Tokyo, Japan). The values of very-low-density-lipoprotein cholesterol (VLDL-C) were calculated by dividing TG with 5 (TG ÷ 5). In addition, by computing the values from different anthropometric and metabolic estimations, various metabolic indices and ratios such as visceral adiposity index (VAI) (mmol L−1), lipid accumulation product (LAP) (mmol L−1), product of triglyceride and glucose (TyG) index, coronary risk index (CRI), atherogenic index (AI), and triglyceride-to-HDL-C ratio (TG/HDL-C) were calculated. Gender-specific formulae were used to calculate VAI and LAP [20, 21]. The TyG index was calculated using general formula [22]. For calculating VAI and LAP, the values of TGs and HDL-C were converted into mmol L−1. CRI was calculated as total TC ÷ HDL-C, whereas AI was calculated as LDL-C ÷ HDL-C [23]. TG/HDL-C ratio was calculated as TGs ÷ HDL-C.
DNA extraction and genotyping
DNA from blood samples was extracted by spin column method using genomic DNA purification kit (Bio Basic, Canada). Allelic discrimination assay for genotyping the FTO rs1421085 variant was run on Applied Biosystems rtPCR machine (ABI 7500, Thermofisher Scientific, USA). For this purpose, the TaqMan® primers/probes assay (Assay ID C___8917103_10, cat. # 4351379, Applied Biosystems Thermo Fisher Scientific Inc., USA) and master mix (part # 4371355, Applied Biosystems Thermo Fisher Scientific Inc., foster city, USA) were utilized. For each experiment, two non-template/negative controls (NTCs) and three positive controls (PCs) for each genotype were included. The twenty percent (20%) of the samples were genotyped twice for reproducibility.
Statistical analysis
Genotypic frequencies in cases and controls were calculated via Chi square (χ2) test whereas allelic frequencies were calculated by direct count. Genotypic and allelic frequencies were reported as counts and percentages. Hardy–Weinberg Equilibrium (HWE) test was carried out for both cases and controls to determine whether the allelic and genotypic frequencies are in HWE. HWE test was performed using an online program [24]. The normality of all quantitative variables was checked via Shapiro–Wilk test. Rank-based inverse normal transformation was carried out for all non-normal quantitative variables. For subsequent analysis, transformed values of quantitative variables were used. All study variables were presented as mean (standard deviation). The association of the FTO rs1421085 with overweight/obesity was sought by assuming multiple genetic models including co-dominant, dominant, recessive, and over-dominant model. For dominant, recessive and over-dominant models, association was determined by binary logistic regression. However, in case of co-dominant model, multinomial logistic regression was used. Age and gender adjusted odd ratio (OR) and 95% confidence intervals (CI) were calculated to determine the risk of overweight/obesity associated with the rs1421085 variant. To find the appropriate mode of inheritance in case of getting association in more than one genetic model, h-index (degree of dominance index) was calculated [25]. The association of the rs1421085 variant with all study variables was determined by linear regression. All tests for finding association between the FTO rs1421085 and obesity-related secondary outcomes were adjusted for confounders such as age, gender, and BMI except anthropometric traits, which were adjusted for age and gender only. Effect size (β) with 95% confidence interval (CI) was determined for all variables. The effects of interaction between the FTO rs1421085 and BMI on metabolic variables were also determined by linear regression. The transformed values of BMI were centered for convenience in the interpretation of interaction effects [26]. Scatter plots were drawn for validation of significant interaction effects. In scatter plots, X-axis showed independent variable (BMI) and Y-axis showed dependent variable (metabolic parameters), whereas intersecting lines represented respective genotypes. To plot interactions, age and gender adjusted predicted values were determined for each dependent variable. All statistical tests having p value < 0.05 were considered significant. All association and interaction analyses were corrected for multiple comparisons by Benjamin–Hochberg method [27]. All statistical analyses were performed using Statistical Package for Social Sciences version 19.0 (SPSS, Inc. Chicago, IL, USA IBM statistics).
Results
The distribution of allelic and genotypic frequencies of the FTO rs1421085
The distribution of allelic and genotypic frequencies of the FTO rs1421085 variant among cases and controls is shown in Table 1. Minor allele frequency (MAF) of the FTO rs1421085 variant was 34% in cases and 31% in controls. The genotypic frequencies of controls (p = 0.14) were in compliance with Hardy–Weinberg Equilibrium (HWE), whereas those of cases were in disequilibrium (p = 0.04). The genotypic frequencies of the rs1421085 in cases were 41.2% TT (wild type), 50% CT (heterozygous mutant), and 8.8% CC (homozygous mutant). Similarly, the genotypic frequencies of the rs1421085 in controls were 50.0% TT (wild type), 38.9% CT (heterozygous mutant), and 11.1% CC (homozygous mutant). Thus, the genotypic frequencies of the FTO rs1421085 variant differed significantly between cases and controls (Table 1).
Association of the FTO rs1421085 with obesity risk and anthropometric parameters
The association between the FTO rs1421085 and obesity risk was observed in co-dominant, dominant, and over-dominant models, which remained significant even after age and gender adjustment (Table 1). Thus, the degree of dominance (h-index) was calculated to identify mode of inheritance which turned out to be over-dominant (hadjusted = 11.85). Thus, according to over-dominant model, the CT genotype of the FTO rs1421085 variant increased 1.583 times the risk of having overweight or obese phenotype (ORadjusted = 1.583, 95% CI 1.147–2.185, padjusted = 0.005). The FTO rs1421085 variant (CT genotype) was also found to be significantly associated with almost all anthropometric measurements (p < 0.05) except height and waist-to-hip ratio (Table 2). All associations retained significance after age and gender adjustment (p < 0.05) and correction for multiple comparisons.
Lack of association of the FTO rs1421085 with obesity-related metabolic parameters
No association of the rs1421085 with obesity-related metabolic parameters (Table 3) (p > 0.05) was observed.
Interaction between the FTO rs1421085 variant and obesity influences multiple metabolic traits
A significant effect of interaction (pinteraction < 0.05) between the FTO rs1421085 and obesity on obesity-related metabolic parameters (except HDL-C) was observed in initial analysis (Table 4). All the interactions retained statistical significance after age and gender adjustments and correction for multiple comparisons. Further validation of the interaction effects by comparing regression slopes (Fig. 1) in follow-up analysis suggested that the CT genotype of the FTO rs1421085 interacts with higher BMI (overweight/obesity) to increase SBP, DBP, TyG index, TG, LDL-C, VLDL-C, CRI, AI, and TG/HDL-C ratio. However, this interaction effect (rs1421085 × BMI) could not be validated for the rest of the parameters including LAP, FBG, fasting insulin, HOMA–IR, and TC in follow-up analysis.
Discussion
Obesity is a multifactorial disorder that necessitates environmental influences for its expression and the higher predisposition of some individuals to weight gain in an obesogenic environment is mainly determined by genetic factors [28]. Obesity-predisposing genetic factors strongly interact with environment or behavior throughout the life of an individual and in a wide range of situations [29]. Thus, the effects of genetic variants that increase susceptibility to obesity can vary from population to population. The variants rs17782313 near MC4R gene and rs9939609/rs1421085 in the FTO gene are considered among key contributors to human polygenic obesity [30]. We previously reported the gender-specific association of the variants MC4R rs17782313, LEP rs7799039, and FTO rs9939609 with overweight/obese phenotype and related anthropometric traits in Pakistani females [31,32,33]. In addition, we also previously reported lack of association of the BDNF rs6265 variant with obesity and related traits [34]. However, we could not study association of the FTO rs1421085 variant with overweight/obesity and obesity-related parameters before. In addition, this association has not been explored by other investigators from Pakistan so far despite the fact that the variant (rs1421085) has recently been predicted as the causal variant for obese phenotype [17]. Though the association of the FTO rs1421085 variant with overweight/obesity has not been previously explored in Pakistani population, however, there are few studies, which investigated the association of FTO variants other than rs1421085 with overweight/obesity in Pakistanis. For instance, Shabana and Hasnain observed the association of three FTO variants rs9939609, rs1121980, and rs9926289 with obesity in Pakistani subjects independent of age and gender [35]. Similarly, another study by Shahid et al. reported the association of rs9939609 with obesity in Pakistanis [36]. On the other hand, Fawwad et al. reported lack of association of the variant rs9939609 with obesity but the variant was found to be associated with the risk of developing type 2 diabetes [37]. By keeping the aforementioned scenario in mind, the present study was undertaken to seek the association of the FTO rs1421085 variant with overweight/obesity and related traits (anthropometric and metabolic) in Pakistani individuals. Among these traits, WSR, % BF, TyG index, CRI, AI, and TG/HDL-C ratio and visceral adiposity markers (VAI and LAP) have never been studied in relation to association with FTO rs1421085 variant in our and in other populations. Moreover, the interaction effects of the FTO rs1421085 and overweight/obesity on obesity-related metabolic traits were also investigated in the current study, which were never sought before in Pakistani as well as in any other population.
The present study reported a significant association of the rs1421085 with overweight/obesity in Pakistani population. The minor allele frequency (MAF) of the FTO variant rs1421085 (C allele) observed in the current study (32%) was comparable with that reported in north Indians (29%) [38]. However, the MAF observed in our study was higher than those observed in Caucasians (11.4%), American Samoans (18.2%), and Samoans (16.8%), but lower as compared to that seen in Chinese (44.8%) [39]. Differences in allele frequencies among various populations located in different geographic regions are attributable to natural selection and neutral genetic drift. Differential selective pressure of environmental factors may also create differences in allele frequencies between populations [40,41,42,43]. In the current study, the frequency of CT genotype differed significantly between overweight/obese and non-obese subjects, while the difference for other genotypes (CC or TT) was not significant. Thus, heterozygotes or CT carriers of the FTO rs1421085 variant showed a greater risk of having obesity as compared to both homozygotes (CC and TT carriers) in our study. Similarly, other studies conducted on Asian [38, 44,45,46], European [47, 48], and American [49, 50] populations also reported a significant association of the rs1421085 with obesity. However, it is important to note that none of aforementioned studies assumed multiple genetic models in association tests and did not report appropriate mode of inheritance. We considered four models of inheritance including co-dominant, dominant, recessive, and over-dominant in association test and found association in more than one model (co-dominant, dominant, and over-dominant). Thus, we then calculated degree of dominance or h-index to find the appropriate mode of inheritance, which turned out to be the over-dominant in our case. In disagreement to the aforementioned studies [38, 44, 46,47,48, 50] and our study, the variant rs1421085 was not found to be associated with obesity in Turkish and Oceanic populations [51, 52]. In genetics, over-dominance is a condition, wherein heterozygote shows different phenotype than any of the homozygote. It is generally explained as heterosis or hybrid vigor, which advantageously increases the survival of heterozygous individuals in the natural selection. Heterosis is progressively being identified in humans [53, 54], but heterotic associations are generally not identified by allele-based linkage techniques [55]. The occurrence of excessive heterozygosity is consistent with over-dominance which might be due to various biological (disassortative mating) and socio-demographic factors that may vary among populations [56]. Moreover, fat storage improves survival chances during famine and scarcity of food that occurred throughout the history of man and it also possibly supports thrifty gene hypothesis [57].
The current study revealed a significant association of the rs1421085 with obesity-related anthropometric traits. Among these traits, the association of the FTO rs1421085 variant with weight, height, BMI, WC, HC, and WHR was investigated in very few studies [39, 47, 49, 58]. Among these studies, Zhang et al. in Croatians, while Albuquerque et al. in Portuguese children reported an association of the rs1421085 with weight, BMI, WC, and HC [47, 58]. Moreover, the rs1421085 was also found to be associated with BMI and WC in White- and African-Americans [49]. In contrast, lack of association between the rs1421085 and obesity-related anthropometric phenotypes was observed in Polynesians [39]. Only Zhang et al. [58] explored the association of the rs1421085 variant with skinfold thicknesses, as we did in our study. However, in contrast to our study, no association of the rs1421085 variant with biceps SFT, triceps SFT, sub-scapular SFT, abdominal SFT, supra-iliac SFT, and thigh SFT was seen. The variability of associations across different populations may be due to their different ethnic backgrounds. Furthermore, in line with the previous reports [47, 49, 58], we found lack of the association of the rs1421085 with height and WHR in our study. In contrast, a significant association of the rs1421085 with WHR was observed in White Americans [49]. According to our knowledge, no study examined the association of the rs1421085 with WSR and % BF. Like WC, WSR is also a useful predictor of central obesity and cardiovascular health [59,60,61]. In addition, WSR was also found to be an effective indicator of mortality risk [62]. Thus, our study highlighted that the rs1421085 may increase the risk of cardiovascular disease and mortality via increasing WC and WSR. Moreover, the association of the genetic variant rs1421085 with skinfold thicknesses and % BF indicated a possible role of the rs1421085 in fat deposition.
Obesity has been strongly linked to hypertension, diabetes, cardiovascular diseases, and dyslipidemia. Therefore, in this study, we determined the association of the rs1421085 with various obesity-related metabolic traits. No association of the FTO rs1421085 was seen with any parameter related to glucose (FBG, fasting insulin levels, HOMA–IR, and TyG index) and lipid (TC, TG, HDL-C, LDL-C, VLDL-C, CRI, AI, and TG/HDL-C ratio) metabolism, visceral adiposity markers (VAI and LAP), and blood pressure. In line with our findings, several studies observed lack of the association of the rs1421085 variant with SBP, DBP, FBG, insulin levels, HOMA–IR, TC, TG, HDL-C, and LDL-C in different populations including Han Chinese, Koreans, European, French Croatians, and Egyptian females [44, 46, 63,64,65,66,67]. However, Karns et al. found the association of the rs1421085 variant with HDL-C in Croatians [64]. Moreover, significant association was seen between this FTO variant and impaired fasting glucose among Japanese and Tunisians [68, 69]. Likewise, Hotta et al. also reported the association of the rs1421085 with hypertension (↑SBP and/or ↑DBP) in Japanese [68]. The observed differences among various studies could be due to several reasons. A potential reason for lack of the association of the FTO rs1421085 with various parameters related to glucose metabolism (FBG, fasting insulin levels, HOMA–IR and TyG index) could be that we did not include diabetic overweight/obese subjects in our study. Moreover, some studies were exclusively carried out on children and females. Thus, age and gender differences among studies may be the cause of discrepancy between outcomes of various studies. It is also noteworthy that we did not find any study in literature that explored the association of the FTO rs1421085 with TyG index, CRI, AI, and TG/HDL-C ratio and visceral adiposity markers (VAI and LAP). Thus, the current study indicated that this FTO variant might have a role in the expression of obese phenotype among Pakistanis but could not influence metabolic traits directly. However, it was observed in the current study that the rs1421085 variant interacted with obesity (FTO rs1421085 × overweight/obesity) to influence the metabolic traits including SBP, DBP, TyG index, TG, LDL-C, VLDL-C, CRI, AI and TG/HDL-C ratio. In the presence of higher BMI, carriers of CT genotype of the rs1421085 showed aberrant metabolic traits than TT/CC homozygotes. It suggests that through interaction with overweight/obesity, this FTO variant may increase the risk of dyslipidemia and hypertension irrespective of age and gender. Consequently, this interaction may increase the proneness of an individual to coronary heart disease via anomalous levels of lipid profile components and elevated values of atherogenic indices (CRI and AI). We did not find any parallel and contrary study in the literature in comparison with our study regarding the effect of interaction between the rs1421085 with BMI (FTO rs1421085 × overweight/obesity) on metabolic traits. It is noteworthy that different metabolic traits may be influenced by genetic variations only in the presence of predisposing environment such as increased BMI [70,71,72].
At this point, some limitations of the current study are indicated. First, the recruited sample size for the present study is modest, while larger sample size provides better investigation of the real effect for SNP association studies. Second, we considered only one variant of the FTO gene; therefore, we cannot be certain about the presence and the association of the other variants of the FTO gene and their association with the overweight or obese phenotype, though we discussed and compared the previously reported associations of FTO variants other than rs1421085 from Pakistan and also our own previously reported studies regarding genetic variants other than the FTO gene variants with the results of the current study. The aforementioned limitations of the current study were attributable to cost and time constraint.
Conclusions
In conclusion, heterozygous genotype (CT) of the FTO rs1421085 may be associated with the risk of having overweight/obese phenotype and related aberrant anthropometric parameters in Pakistani population. In addition, the interaction between CT genotype and overweight/obesity may lead to obesity-related aberrant metabolic parameters.
Data availability
All data generated or analysed during this study are included in this article.
References
Dubois L, Ohm Kyvik K, Girard M, Tatone-Tokuda F, Pérusse D, Hjelmborg J, Skytthe A, Rasmussen F, Wright MJ, Lichtenstein P, Martin NG (2012) Genetic and Environmental Contributions to Weight, Height, and BMI from Birth to 19 Years of Age: an International Study of Over 12,000 Twin Pairs. PLoS One 7(2):e30153. https://doi.org/10.1371/journal.pone.0030153
Qi L, Cho YA (2008) Gene-environment interaction and obesity. Nutr Rev 66(12):684–694. https://doi.org/10.1111/j.1753-4887.2008.00128.x
Frayling TM (2012) Are the causes of obesity primarily environmental? No. BMJ 345:e5844. https://doi.org/10.1136/bmj.e5844
McPherson R (2007) Genetic contributors to obesity. Can J Cardiol 23(Suppl A):23A–27A. https://doi.org/10.1016/S0828-282X(07)71002-4
Tan LJ, Zhu H, He H, Wu KH, Li J, Chen XD, Zhang JG, Shen H, Tian Q, Krousel-Wood M, Papasian CJ, Bouchard C, Perusse L, Deng HW (2014) Replication of 6 obesity genes in a meta-analysis of genome-wide association studies from diverse ancestries. PLoS One 9(5):e96149. https://doi.org/10.1371/journal.pone.0096149
Xia Q, Grant SFA (2013) The genetics of human obesity. Ann N Y Acad Sci 1281(1):178–190. https://doi.org/10.1111/nyas.12020
Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L, Bouchard C (2006) The human obesity gene map: the 2005 update. Obesity (Silver Spring, Md) 14(4):529–644. https://doi.org/10.1038/oby.2006.71
Rosenberg NA (2011) A population-genetic perspective on the similarities and differences among worldwide human populations. Hum Biol 83(6):659–684. https://doi.org/10.3378/027.083.0601
McClellan J, King M-C (2010) Genetic heterogeneity in human disease. Cell 141(2):210–217. https://doi.org/10.1016/j.cell.2010.03.032
Zeng Z, Garcia-Bertrand R, Calderon S, Li L, Zhong M, Herrera RJ (2014) Extreme genetic heterogeneity among the nine major tribal Taiwanese island populations detected with a new generation Y23 STR system. Forensic Sci Int Genet 12:100–106. https://doi.org/10.1016/j.fsigen.2014.05.004
Grant SFA, Bradfield JP, Zhang H, Wang K, Kim CE, Annaiah K, Santa E, Glessner JT, Thomas K, Garris M, Frackelton EC, Otieno FG, Shaner JL, Smith RM, Imielinski M, Chiavacci RM, Li M, Berkowitz RI, Hakonarson H (2009) Investigation of the locus near MC4R with childhood obesity in Americans of European and African ancestry. Obesity (Silver Spring, Md) 17(7):1461–1465. https://doi.org/10.1038/oby.2009.53
Pigeyre M, Saqlain M, Turcotte M, Raja GK, Meyre D (2018) Obesity genetics: insights from the Pakistani population. Obes Rev 19(3):364–380. https://doi.org/10.1111/obr.12644
Wang K, Li W-D, Zhang CK, Wang Z, Glessner JT, Grant SFA, Zhao H, Hakonarson H, Price RA (2011) A Genome-Wide Association Study on Obesity and Obesity-Related Traits. PLOS One 6(4):e18939. https://doi.org/10.1371/journal.pone.0018939
Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I, Jonsdottir T, Olafsdottir EJ, Olafsdottir GH, Jonsson T, Jonsson F, Borch-Johnsen K, Hansen T, Andersen G, Jorgensen T, Lauritzen T, Aben KK, Verbeek AL, Roeleveld N, Kampman E, Yanek LR, Becker LC, Tryggvadottir L, Rafnar T, Becker DM, Gulcher J, Kiemeney LA, Pedersen O, Kong A, Thorsteinsdottir U, Stefansson K (2009) Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41(1):18–24. https://doi.org/10.1038/ng.274
Fawcett KA, Barroso I (2010) The genetics of obesity: FTO leads the way. Trends Genet 26(6):266–274. https://doi.org/10.1016/j.tig.2010.02.006
Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O’Rahilly S, Schofield CJ (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318(5855):1469–1472. https://doi.org/10.1126/science.1151710
Claussnitzer M, Dankel SN, Kim K-H, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, Abdennur NA, Liu J, Svensson P-A, Hsu Y-H, Drucker DJ, Mellgren G, Hui C-C, Hauner H, Kellis M (2015) FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373(10):895–907. https://doi.org/10.1056/NEJMoa1502214
Jackson AS, Pollock ML (1985) Practical assessment of body composition. Phys Sportsmed 13(5):76–90. https://doi.org/10.1080/00913847.1985.11708790
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. https://doi.org/10.1007/BF00280883
Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A (2010) Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4):920–922. https://doi.org/10.2337/dc09-1825
Kahn HS (2005) The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 5:26. https://doi.org/10.1186/1471-2261-5-26
Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6(4):299–304. https://doi.org/10.1089/met.2008.0034
Kazemi T, Hajihosseini M, Moossavi M, Hemmati M, Ziaee M (2018) Cardiovascular risk factors and atherogenic indices in an Iranian population: Birjand East of Iran. Clin Med Insights Cardiol 12:1179546818759286. https://doi.org/10.1177/1179546818759286
Rodriguez S, Gaunt TR, Day INM (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169(4):505–514. https://doi.org/10.1093/aje/kwn359
Zintzaras E, Santos M (2011) Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index. BMC Med Res Methodol 11:171. https://doi.org/10.1186/1471-2288-11-171
Williams R (2015) Interpreting interaction effects; Interaction effects and centering. Notre Dame, Indiana, US
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological). https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
Levin BE (2005) Factors promoting and ameliorating the development of obesity. Physiol Behav 86(5):633–639. https://doi.org/10.1016/j.physbeh.2005.08.054
Reddon H, Gueant JL, Meyre D (2016) The importance of gene-environment interactions in human obesity. Clin Sci (London, England: 1979) 130(18):1571–1597. https://doi.org/10.1042/cs20160221
Choquet H, Meyre D (2011) Genetics of Obesity: What have we Learned? Curr Genomics 12(3):169–179. https://doi.org/10.2174/138920211795677895
Rana S, Rahmani S, Mirza S (2018) MC4R variant rs17782313 and manifestation of obese phenotype in Pakistani females. RSC Adv 8(30):16957–16972. https://doi.org/10.1039/C8RA00695D
Shahid A, Rana S, Saeed S, Imran M, Afzal N, Mahmood S (2013) Common Variant of FTO Gene, rs9939609, and Obesity in Pakistani Females. BioMed Res Int 2013:7. https://doi.org/10.1155/2013/324093
Shahid A, Rana S, Mahmood S, Saeed S (2015) Role of leptin G-2548A polymorphism in age- and gender-specific development of obesity. J Biosci 40(3):521–530. https://doi.org/10.1007/s12038-015-9536-2
Rana S, Mirza S (2018) The BDNF rs6265 variant may interact with overweight and obesity to influence obesity-related physical, metabolic and behavioural traits in Pakistani individuals. Ann Hum Biol 45(6–8):496–505. https://doi.org/10.1080/03014460.2018.1561947
Shabana Hasnain S (2015) Effect of the common fat mass and obesity associated gene variants on obesity in Pakistani population: a case-control study. BioMed Res Int 2015:8. https://doi.org/10.1155/2015/852920
Shahid SU, Shabana Rehman A, Hasnain S (2016) Role of a common variant of Fat Mass and Obesity associated (FTO) gene in obesity and coronary artery disease in subjects from Punjab, Pakistan: a case control study. Lipids Health Dis 15:29. https://doi.org/10.1186/s12944-016-0200-0
Fawwad A, Siddiqui IA, Basit A, Zeeshan NF, Shahid SM, Nawab SN, Siddiqui S (2016) Common variant within the FTO gene, rs9939609, obesity and type 2 diabetes in population of Karachi, Pakistan. Diabetes Metab Syndr 10(1):43–47. https://doi.org/10.1016/j.dsx.2015.02.001
Srivastava A, Srivastava N, Mittal B, Prakash J, Srivastava P, Srivastava N (2016) Association of rs9939609 and rs1421085 with obesity risk in north Indian population. J Hum Genet. https://doi.org/10.21088/ip.2347.1506.4216.1
Karns R, Viali S, Tuitele J, Sun G, Cheng H, Weeks DE, McGarvey ST, Deka R (2012) Common variants in FTO are not significantly associated with obesity-related phenotypes among Samoans of Polynesia. Ann Hum Genet 76(1):17–24. https://doi.org/10.1111/j.1469-1809.2011.00686.x
Ma L, Xue Y, Liu Y, Wang Z, Cui X, Li P, Fu S (2005) Polymorphism study of seven SNPs at ADH genes in 15 Chinese populations. Hereditas 142(2005):103–111. https://doi.org/10.1111/j.1601-5223.2005.01910.x
Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T (2006) Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 80(3):282–297. https://doi.org/10.1016/j.clpt.2006.05.012
Sivakova D, Zacharova M, Gasparovic J, Raslova K, Wsolova L, Basistova Z, Blazicek P (2006) Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. Coll Antropol 30(2):387–394. https://doi.org/10.1127/0003-5548/2009/0035
Lan Q, Shen M, Garcia-Rossi D, Chanock S, Zheng T, Berndt SI, Puri V, Li G, He X, Welch R, Zahm SH, Zhang L, Zhang Y, Smith M, Wang SS, Chiu BCH, Linet M, Hayes R, Rothman N, Yeager M (2007) Genotype frequency and FST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics 59(11):839–852. https://doi.org/10.1007/s00251-007-0253-3
Cha SW, Choi SM, Kim KS, Park BL, Kim JR, Kim JY, Shin HD (2008) Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. Obesity (Silver Spring, Md) 16(9):2187–2189. https://doi.org/10.1038/oby.2008.314
Chuenta W, Phonrat B, Tungtrongchitr A, Limwongse C, Chongviriyaphan N, Santiprabhob J, Tungtrongchitr R (2015) Common variations in the FTO gene and obesity in Thais: a family-based study. Gene 558(1):75–81. https://doi.org/10.1016/j.gene.2014.12.050
Wang L, Yu Q, Xiong Y, Liu L, Zhang X, Zhang Z, Wu J, Wang B (2013) Variant rs1421085 in the FTO gene contribute childhood obesity in Chinese children aged 3–6 years. Obes Res Clin Pract 7(1):e14–e22. https://doi.org/10.1016/j.orcp.2011.12.007
Albuquerque D, Nóbrega C, Manco L (2013) Association of FTO polymorphisms with obesity and obesity-related outcomes in Portuguese children. PLoS One 8(1):e54370. https://doi.org/10.1371/journal.pone.0054370
Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougneres P, Kovacs P, Marre M, Balkau B, Cauchi S, Chevre JC, Froguel P (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39(6):724–726. https://doi.org/10.1038/ng2048
Bressler J, Kao WHL, Pankow JS, Boerwinkle E (2010) Risk of Type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study. PLoS One 5(5):e10521. https://doi.org/10.1371/journal.pone.0010521
Villalobos-Comparan M, Teresa Flores-Dorantes M, Teresa Villarreal-Molina M, Rodriguez-Cruz M, Garcia-Ulloa AC, Robles L, Huertas-Vazquez A, Saucedo-Villarreal N, Lopez-Alarcon M, Sanchez-Munoz F, Dominguez-Lopez A, Gutierrez-Aguilar R, Menjivar M, Coral-Vazquez R, Hernandez-Stengele G, Vital-Reyes VS, Acuna-Alonzo V, Romero-Hidalgo S, Ruiz-Gomez DG, Riano-Barros D, Herrera MF, Gomez-Perez FJ, Froguel P, Garcia-Garcia E, Teresa Tusie-Luna M, Aguilar-Salinas CA, Canizales-Quinteros S (2008) The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring, Md) 16(10):2296–2301. https://doi.org/10.1038/oby.2008.367
Ohashi J, Naka I, Kimura R, Natsuhara K, Yamauchi T, Furusawa T, Nakazawa M, Ataka Y, Patarapotikul J, Nuchnoi P, Tokunaga K, Ishida T, Inaoka T, Matsumura Y, Ohtsuka R (2007) FTO polymorphisms in oceanic populations. J Hum Genet 52(12):1031–1035. https://doi.org/10.1007/s10038-007-0198-2
Solak M, Ozdemir Erdogan M, Yildiz SH, Ucok K, Yuksel S, Arikan Terzi ES, Bestepe A (2014) Association of obesity with rs1421085 and rs9939609 polymorphisms of FTO gene. Mol Biol Rep 41(11):7381–7386. https://doi.org/10.1007/s11033-014-3627-2
Pooley EC, Fairburn CG, Cooper Z, Sodhi MS, Cowen PJ, Harrison PJ (2004) A 5-HT2C receptor promoter polymorphism (HTR2C—759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet Part B Neuropsychiatr Genet 126b(1):124–127. https://doi.org/10.1002/ajmg.b.20143
Morahan G, Huang D, Wu M, Holt BJ, White GP, Kendall GE, Sly PD, Holt PG (2002) Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet (London, England) 360(9331):455–459. https://doi.org/10.1016/s0140-6736(02)09676-9
Comings DE, MacMurray JP (2000) Molecular heterosis: a review. Mol Genet Metab 71(1–2):19–31. https://doi.org/10.1006/mgme.2000.3015
Lachance J (2008) A fundamental relationship between genotype frequencies and fitnesses. Genetics 180(2):1087–1093. https://doi.org/10.1534/genetics.108.093518
O’Rourke RW (2014) Metabolic thrift and the genetic basis of human obesity. Ann Surg 259(4):642–648. https://doi.org/10.1097/SLA.0000000000000361
Zhang G, Karns R, Narancic NS, Sun G, Cheng H, Missoni S, Durakovic Z, Rudan P, Chakraborty R, Deka R (2010) Common SNPs in FTO gene are associated with obesity related anthropometric traits in an island population from the eastern Adriatic coast of Croatia. PLoS One 5(4):e10375. https://doi.org/10.1371/journal.pone.0010375
Shen S, Lu Y, Qi H, Li F, Shen Z, Wu L, Yang C, Wang L, Shui K, Yao W, Qiang D, Yun J, Zhou L (2017) Waist-to-height ratio is an effective indicator for comprehensive cardiovascular health. Sci Rep 7:43046. https://doi.org/10.1038/srep43046
Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB (2002) Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 76(4):743–749. https://doi.org/10.1093/ajcn/76.4.743
Hsieh S, Yoshinaga H, Muto T (2003) Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes 27(5):610. https://doi.org/10.1038/sj.ijo.0802259
Ashwell M, Mayhew L, Richardson J, Rickayzen B (2014) Waist-to-height ratio is more predictive of years of life lost than body mass index. PLoS One 9(9):e103483. https://doi.org/10.1371/journal.pone.0103483
Wang T, Huang Y, Xiao XH, Wang DM, Diao CM, Zhang F, Xu LL, Zhang YB, Li WH, Zhang LL, Zhang Y, Sun XF, Zhang Q (2010) The association between common genetic variation in the FTO gene and metabolic syndrome in Han Chinese. Chin Med J 123(14):1852–1858. https://doi.org/10.3760/cma.j.issn.0366-6999.2010.14.005
Karns R, Zhang G, Jeran N, Havas-Augustin D, Missoni S, Niu W, Indugula SR, Sun G, Durakovic Z, Narancic NS, Rudan P, Chakraborty R, Deka R (2011) Replication of genetic variants from genome-wide association studies with metabolic traits in an island population of the Adriatic coast of Croatia. Eur J Hum Genet 19(3):341–346. https://doi.org/10.1038/ejhg.2010.178
Abdel Adel A H, Rahman AESAM, El Baz Rizk A, Wafa Alaa M, El Zekred Abeer S (2018) Association of obesity with rs1421085 and rs9939609 polymorphisms of fto gene with t2 dm in Egyptian females. Int J Pharm Pharm Sci 10(9):73–78. https://doi.org/10.22159/ijpps.2018v10i9.22747
Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M, Li YR, Liu K, McDonough CW, Meijs MF, Middelberg RP, Musunuru K, Nelson CP, O’Connell JR, Padmanabhan S, Pankow JS, Pankratz N, Rafelt S, Rajagopalan R, Romaine SP, Schork NJ, Shaffer J, Shen H, Smith EN, Tischfield SE, van der Most PJ, van Vliet-Ostaptchouk JV, Verweij N, Volcik KA, Zhang L, Bailey KR, Bailey KM, Bauer F, Boer JM, Braund PS, Burt A, Burton PR, Buxbaum SG, Chen W, Cooper-Dehoff RM, Cupples LA, deJong JS, Delles C, Duggan D, Fornage M, Furlong CE, Glazer N, Gums JG, Hastie C, Holmes MV, Illig T, Kirkland SA, Kivimaki M, Klein R, Klein BE, Kooperberg C, Kottke-Marchant K, Kumari M, LaCroix AZ, Mallela L, Murugesan G, Ordovas J, Ouwehand WH, Post WS, Saxena R, Scharnagl H, Schreiner PJ, Shah T, Shields DC, Shimbo D, Srinivasan SR, Stolk RP, Swerdlow DI, Taylor HA Jr, Topol EJ, Toskala E, van Pelt JL, van Setten J, Yusuf S, Whittaker JC, Zwinderman AH, Anand SS, Balmforth AJ, Berenson GS, Bezzina CR, Boehm BO, Boerwinkle E, Casas JP, Caulfield MJ, Clarke R, Connell JM, Cruickshanks KJ, Davidson KW, Day IN, de Bakker PI, Doevendans PA, Dominiczak AF, Hall AS, Hartman CA, Hengstenberg C, Hillege HL, Hofker MH, Humphries SE, Jarvik GP, Johnson JA, Kaess BM, Kathiresan S, Koenig W, Lawlor DA, Marz W, Melander O, Mitchell BD, Montgomery GW, Munroe PB, Murray SS, Newhouse SJ, Onland-Moret NC, Poulter N, Psaty B, Redline S, Rich SS, Rotter JI, Schunkert H, Sever P, Shuldiner AR, Silverstein RL, Stanton A, Thorand B, Trip MD, Tsai MY, van der Harst P, van der Schoot E, van der Schouw YT, Verschuren WM, Watkins H, Wilde AA, Wolffenbuttel BH, Whitfield JB, Hovingh GK, Ballantyne CM, Wijmenga C, Reilly MP, Martin NG, Wilson JG, Rader DJ, Samani NJ, Reiner AP, Hegele RA, Kastelein JJ, Hingorani AD, Talmud PJ, Hakonarson H, Elbers CC, Keating BJ, Drenos F (2012) Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 91(5):823–838. https://doi.org/10.1016/j.ajhg.2012.08.032
Robiou-du-Pont S, Bonnefond A, Yengo L, Vaillant E, Lobbens S, Durand E, Weill J, Lantieri O, Balkau B, Charpentier G, Marre M, Froguel P, Meyre D (2013) Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int J Obes (Lond) 37(7):980–985. https://doi.org/10.1038/ijo.2012.175
Hotta K, Kitamoto T, Kitamoto A, Mizusawa S, Matsuo T, Nakata Y, Kamohara S, Miyatake N, Kotani K, Komatsu R, Itoh N, Mineo I, Wada J, Yoneda M, Nakajima A, Funahashi T, Miyazaki S, Tokunaga K, Masuzaki H, Ueno T, Hamaguchi K, Tanaka K, Yamada K, Hanafusa T, Oikawa S, Yoshimatsu H, Sakata T, Matsuzawa Y, Nakao K, Sekine A (2011) Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population. J Hum Genet 56(9):647–651. https://doi.org/10.1038/jhg.2011.74
Elouej S, Belfki-Benali H, Nagara M, Lasram K, Attaoua R, Sallem OK, Kamoun I, Chargui M, Romdhane L, Jamoussi H, Turki Z, Abid A, Ben Slama C, Bahri S, Abdelhak S, Grigorescu F, Ben Romdhane H, Kefi R (2016) Association of rs9939609 polymorphism with metabolic parameters and FTO risk haplotype among tunisian metabolic syndrome. Metab Syndr Relat Disord 14(2):121–128. https://doi.org/10.1089/met.2015.0090
Davis CL, Wang X, Snieder H, Treiber FA (2005) Genetic and environmental determinants of lipid profile in black and white youth: a study of four candidate genes. Ethn Dis 15(4):568–577
Villarreal-Molina T, Posadas-Romero C, Romero-Hidalgo S, Antúnez-Argüelles E, Bautista-Grande A, Vargas-Alarcón G, Kimura-Hayama E, Canizales-Quinteros S, Juárez-Rojas JG, Posadas-Sánchez R, Cardoso-Saldaña G, Medina-Urrutia A, González-Salazar MdC, Martínez-Alvarado R, Jorge-Galarza E, Carnevale A (2012) The ABCA1 Gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study. PLoS One 7(11):e49285. https://doi.org/10.1371/journal.pone.0049285
Manuck SB, McCaffery JM (2014) Gene-Environment Interaction. Annu Rev Psychol 65(1):41–70. https://doi.org/10.1146/annurev-psych-010213-115100
Acknowledgements
Authors are thankful to Mr. Saad Mirza, Ms. Soma Rahmani, and Ms. Ayesha Sultana for their contribution in sample collection. The authors would also like to thank all the individuals who participated in the study.
Funding
This work was supported by a recurring grant given by the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan; and by a research grant awarded by the Higher Education Commission (HEC) of Pakistan (Ref. No. 5740/Sindh/NRPU/R&D/HEC/2016). The funding bodies did not play any role in the design of the study, sample collection, data collection, data analysis and interpretation or in writing the manuscript.
Author information
Authors and Affiliations
Contributions
SR contributed to the study concept and design, sample, and data collection, analysis and interpretation of the data, critical revision of the manuscript for important intellectual content, and funding. AAB performed the experiments, collected data, participated in data analysis and interpretation, and drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional ethical committee and Advanced Studies and Research Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants or parents/guardian of the participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rana, S., Bhatti, A.A. Association and interaction of the FTO rs1421085 with overweight/obesity in a sample of Pakistani individuals. Eat Weight Disord 25, 1321–1332 (2020). https://doi.org/10.1007/s40519-019-00765-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40519-019-00765-x